Warning: file_put_contents(/home/customer/www/dailylegalbriefing.com/public_html/wp-content/uploads/wpo/images/wpo_logo_small.png.webp): failed to open stream: Disk quota exceeded in /home/customer/www/dailylegalbriefing.com/public_html/wp-content/plugins/wp-optimize/vendor/rosell-dk/webp-convert/src/Convert/Converters/Gd.php on line 428
Mylan Issues Urgent Recall for Insulin Pens – Breaking Legal News & Current Law Headlines | Daily Legal Briefing
Warning: unlink(/tmp/jnewslibrary-MXz38Z.tmp): No such file or directory in /home/customer/www/dailylegalbriefing.com/public_html/wp-admin/includes/class-wp-filesystem-ftpext.php on line 142
Breaking Legal News & Current Law Headlines | Daily Legal Briefing
  • Home
  • Hot Topics
  • Breaking
  • Business
  • Big Law
  • Small Law
  • Law School
  • Legal Tech
No Result
View All Result
No Result
View All Result
Breaking Legal News & Current Law Headlines | Daily Legal Briefing
No Result
View All Result
Home Business

Mylan Issues Urgent Recall for Insulin Pens

Daily Legal Briefing by Daily Legal Briefing
January 21, 2022
in Business
0
Mylan Issues Urgent Recall for Insulin Pens
4
SHARES
32
VIEWS
Share on FacebookShare on Twitter


Mylan Pharmaceuticals is recalling certain Semglee prefilled insulin injection pens because they may not be properly labeled.


Earlier this week, Mylan Pharmaceuticals made an urgent recall announcement for one batch of Semglee prefilled insulin injection pens because the pens are missing their labels. According to the notice, the recall includes pens in batch No. BF20003118. They expire on August 2022 and include “100 units/ml (U-100), 3mL prefilled pens in cartons of five.”

Image of a Warning Sign
Warning Sign; image courtesy of Peter-Lomas via Pixabay, www.pixabay.com

Though the cartons were all properly labeled, some of the pens are not. According to parent company Viatris, “in a diabetes patient taking more than one kind of insulin, this could lead to a mix-up of products/strengths, resulting in administration of the wrong insulin. Administration of the wrong insulin could result in less optimal glycemic control (either high or low blood sugar) which could result in serious complications.”

For now, Mylan is asking wholesalers and retailers to quarantine products from the batch. Customers who have the recalled pens should contact Stericycle for instructions on how to return the pens at 888-843-0255.

If you have questions or concerns about the recall, contact Viatris at customer.service@viatris.com or 800-796-9526. 

Sources:

Insulin pens recalled for a problem that might lead to the wrong amount being injected

Mylan Pharmaceuticals Inc., a Viatris Company, Conducting Voluntary Recall of One Batch of Semglee® (insulin glargine injection), 100 units/mL (U-100), 3 mL Prefilled Pens, Due to the Potential for a Missing Label in the Batch



Click to Read Original Article

Previous Post

Three Traits That Make For An Unrivaled Attorney

Next Post

Immigration court system needs independence from the DOJ, ABA representative says at congressional hearing

Daily Legal Briefing

Daily Legal Briefing

Related Posts

Mark Wagoner Appointed Chairman of the Board of Directors of Paramount Health Care
Business

Mark Wagoner Appointed Chairman of the Board of Directors of Paramount Health Care

by Daily Legal Briefing
January 28, 2023
Evisort Debuts New Brand Identity Reflecting Generative AI and Focus on the Future of Connected Contract Data
Business

Evisort Debuts New Brand Identity Reflecting Generative AI and Focus on the Future of Connected Contract Data

by Daily Legal Briefing
January 27, 2023
Legal Terms Your Business Should Know When Working Sales
Business

Legal Terms Your Business Should Know When Working Sales

by Daily Legal Briefing
January 27, 2023
Business

What are the Different Services Offered by a Notary?

by Daily Legal Briefing
January 27, 2023
Getting Trained for Public Service is a Bonus–Understand the Benefits
Business

Getting Trained for Public Service is a Bonus–Understand the Benefits

by Daily Legal Briefing
January 27, 2023
Next Post
Racial and ethnic justice cases reveal ideological rift in the courts

Immigration court system needs independence from the DOJ, ABA representative says at congressional hearing

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Premium Content

The Bumpy (But Rewarding) Road To Restarting Your Legal Career

The Bumpy (But Rewarding) Road To Restarting Your Legal Career

November 22, 2022
EXCLUSIVE No. 2 federal prosecutor in Manhattan leaves post for Fried Frank

EXCLUSIVE No. 2 federal prosecutor in Manhattan leaves post for Fried Frank

December 1, 2021
In A Post-Pandemic Workplace, Can Women Lawyers Have It All?

In A Post-Pandemic Workplace, Can Women Lawyers Have It All?

March 4, 2022

Browse by Category

  • Big Law
  • Breaking
  • Business
  • Hot Topics
  • Law School
  • Legal Tech
  • Small Law

About US

Breaking Legal News & Current Law Headlines | Daily Legal Briefing.
Online coverage of breaking legal news and current law headlines from around the US. Top stories, videos, insight, and in-depth analysis.

Categories

  • Big Law
  • Breaking
  • Business
  • Hot Topics
  • Law School
  • Legal Tech
  • Small Law

Recent Updates

  • With Layoffs Lurking, Does Biglaw Pass The Vibe Check?
  • A Law Firm That’s A ‘Big Happy Family’ Is A Red Flag
  • Need To Go To Trial? The Best Trial Practices Out There

© 2021 Daily Legal Briefing | Breaking Legal News & Current Law Headlines

No Result
View All Result
  • Contact Us
  • Home

© 2021 Daily Legal Briefing | Breaking Legal News & Current Law Headlines

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?

Warning: unlink(/tmp/jnewsfirstload-MoJK9o.tmp): No such file or directory in /home/customer/www/dailylegalbriefing.com/public_html/wp-admin/includes/class-wp-filesystem-ftpext.php on line 142